INTRAVENOUS NURSING...N E W Z E A L A N D INTRAVENOUS NURSING INCORPORATED SOCIETY SINCE 2006 ISSUE 2 June 2018 EDITOR Ally Hale EDITORIAL Conference Conferences are one of the few
Post on 13-Mar-2020
3 Views
Preview:
Transcript
N E W Z E A L A N D
INTRAVENOUS NURSING
INCORPORATED SOCIETY SINCE 2006
ISSUE 2 June 2018
www.ivnnz.co.nz EDITOR Ally Hale
EDITORIAL Conference
Conferences are one of the few professional constants
in which health professionals can share their work and
network but economic uncertainty in healthcare has
resulted in a more discerning approach by health
organisations in their allocation of funding.
Nurses, being the largest professional group in
healthcare are strongly affected by cost reductions and
rely on the strength of conference content to build a
business case to attend. The programme is the greatest
challenge and often a balancing act with the potential
to make or break the event. With all good intents and
purpose, delegates should leave feeling energised,
motivated and bursting with ideas. If less than
captivated, they may doodle, tinker with phones or
daydream. What then is the recipe for success?
Previously you have told us that quality speakers,
original presentations, creative posters and technology
whets the appetite.
In Rotorua, we were unquestionably treated to some
very exciting research and innovative practice from
around the globe. The main ingredient, renowned
keynote speaker Dr. Vineet Chopra, charmed delegates
with his own brand of MAGIC. Diverse topics and quality
presentations further tantalised taste buds ensuring
there was something to appeal to everyone.
INNZ Inc. offer our congratulations to the following
winners: Best First-time Presenter- Jill Archer (Waikato),
Best-Presenter-Sam Keogh (Brisbane, Australia) and
Best Poster- Claire Rickard (Brisbane, Australia)
Cont. Page 3
MISSION STATEMENT A commitment to excellence in
Infusion Practice
IN THIS ISSUE Editorial
Ally Hale
President’s Annual Report
AGM - Kate Laidlow
Education
Jenny Heretini
Conference Report
Glosan Sadiasa-Manzhula
Conference Feedback
Ellen Jones
Departments
Editorial, IVNNZ Inc. Executive minutes,
Membership application form, IVNNZ Inc. Forum,
CVAD Workshop, Events.
IVNNZ Inc. is proud to be an
international affiliate of the
Infusion Nurse Society (INS)
of America
ISSUE 2 June 2018 Page 2 www.ivnnz.co.nz
ISSUE 2 June 2018 Page 3 www.ivnnz.co.nz
Cont. from Page 1
sponsored by NZ Medical and Scientific, IVNNZ Inc. and
Reynard Health Supplies respectively.
Combined with cutting- edge technology, these
ingredients certainly packed a punch and delivered food
for thought. Add a sprinkle of humour, serve warmly to
friends and there you have it …...the proverbial icing on
the cake!
Reconnecting at conference is a reminder of what
motivates us – like-minded colleagues and friends sharing
the same passion and building strong connections. More
importantly is the promise of what can be accomplished
through working together to achieve excellence in clinical
practice and patient safety within the sphere of infusion
therapy.
Did we get the recipe right?
Your feedback told us we hit the brief!
IVNNZ Inc. wish to thank all the participants, without
whom, the success of the Rotorua conference would not
have been possible. We look forward to welcoming you
to the South Island in 2020. Venue and dates to be
confirmed.
IVNNZ Inc. gratefully acknowledges our Corporate
Sponsorship.
Without your continued support, advancements in
research and the wonderful arena to network and share
innovative practice would not be possible.
Ally Hale
IVNNZ Inc. Editor
Intravenous Nursing New Zealand Inc.
(IVNNZ Inc.)
Annual General Meeting (AGM)
Thursday 15th March 2018 – Rotorua
ANNUAL REPORT
Mission Statement: A commitment to excellence in
Infusion Therapy Practice with ongoing quality
improvements to patient care.
It is with great pleasure I present the President’s report at
the IVNNZ Inc. Annual General Meeting. This report
represents the activities of the IVNNZ Inc. Executive
Committee over the past 12 months. I would like to
acknowledge our executive committee members and
express my personal thanks to: Fiona Williams -Treasurer
and Conference Convener 2018, Ellen Jones-Secretary,
Lynette Lennox-Educator, Jenny Heretini-Second-in-
Charge (2IC) Educator, Catharine O’Hara-Editor and Ally
Hale-Private Sector Representative and 2018 Conference
Convener.
All work completed for IVNNZ Inc. is additional to
established busy employment commitments. The
executive’s collective vision, productivity, generous
personal commitment and great teamwork have further
shaped this organisation into the internationally
recognised society that it is. This does not happen without
each one of you. Thank you.
IVNNZ Inc. acknowledges the executive member’s
employers. Their support and encouragement for their
respective members has enabled us to continue the
important role of leading and developing this
organisation.
Incorporated Society Rules
In accordance with Incorporated Society Rules, IVNNZ Inc.
are required to hold an AGM. The 2017 Financial Report
was presented by Fiona Williams at the IVNNZ Inc. forum
held last year in Auckland. Future AGMs will continue to
coincide with the IVNNZ Inc. forums and or conferences.
President’s Annual Report
ISSUE 2 June 2018 Page 4 www.ivnnz.co.nz
Membership
Retaining and recruiting membership continues to be an
area of focus for development.
Total Membership = 230
Individual membership = 211
Life members = 3
Honorary member = 1
Corporate members = 15
IVNNZ Inc. extends our gratitude to all corporate
members for their assistance with conferences, education
awards and individual funding. Corporate support
provides a forum for speakers to share knowledge,
augment education and, network with clinical colleagues.
Medical product specialists are a much- valued resource
providing support and exposure to the latest innovations
for clinical practice.
International Membership-Affiliated member of Infusion
Nurses Society (INS)
IVNNZ Inc. became an affiliated member of INS in 2010
and receives the following benefits:
Four complimentary INS memberships which include
complimentary subscriptions to the Journal of Infusion
Nursing (hard copy and electronic). Memberships are
exclusive to members of the executive committee.
One complimentary hard copy of Infusion Nursing
Standards of Practice and Policies and Procedure for
Infusion Nursing.
IVNNZ Inc. access to electronic articles from Journal of
Infusion Nursing
Global infusion nurses networking
Global Networking
IVNNZ Inc. would like to acknowledge the work and close
links being forged with the Alliance for Vascular Access,
Teaching and Research (AVATAR). This group work from
Griffith University, Brisbane, Australia and are led by
Professor Claire Rickard. Studies such as the One Million
Global (OMG) peripheral intravenous catheter study are
conducted by this group. A more detailed report and links
to the group are available on our web site.
It is hoped that we will forge a stronger academic
relationship with AVATAR in future years by becoming
research sites, the sharing of academic writings and the
development of Australasian guidelines for infusion
management.
Education
The CNS /Educator Forums provide an opportunity for
nurses working with advanced infusion therapy. Forums
are held annually providing an opportunity to network,
collectively brainstorm and develop strategies to improve
intravenous nursing nationwide. A special thank you to
Lynette Lennox whose leadership has facilitated in the
continuation of these educational infusion forums.
Central Venous Access Device (CVAD) Workshops Level 1
Education programmes require considerable preparation
and organisation. Four central venous access device
(CVAD) workshops were held in 2017. Members will note
that there has been a change in title and content to
reflect current thinking for CVAD management. The venue
has also been changed to be more cost effective. Thank
you to Lynette Lennox and Jenny Heretini for your
forward thinking in instigating these changes and for your
extensive time and contribution to these education
programmes.
The 2018 Education Calendar can be found on the IVNNZ
Inc. website.
Grants, Scholarships and Awards
1. Education, Study and Research Grant: Poonam Kumari
(Waitemata) took advantage of this grant, receiving
financial assistance to attend the 2017 Australian
Vascular Access Society (AVAS) conference held in
Perth, Australia.
2. IVNNZ Inc. Scholarship to attend an international
conference related to infusion therapy (established
2009): Successful recipients were Fiona Williams
(Tauranga) 2016 and Jenny Heretini (Waikato) 2017
who also attended the AVAS conference in Perth.
Presidents’ Award
Leads by example in their own clinical practice, advancing
education and generously share their knowledge with
others.
Tanya Clarke (Gold Coast Hospital, Australia)) received the
President’s Award at the 15th IVNNZ Inc. conference held
in Christchurch 2016.
Service Award
Works tirelessly behind the scenes to advance education
and show that extra commitment over and beyond what is
required.
Christine Beasley and Heather Hocking were the
recipients of the Service Award at the 15th IVNNZ Inc.
conference.
ISSUE 2 June 2018 Page 5 www.ivnnz.co.nz
IVNNZ Inc. extends congratulations to all recipients.
Strategic Plan 2016 to 2022-available on website
IVNNZ Inc. strategies are to:
1. Promote quality and safe infusion therapy practices for
Aotearoa, New Zealand.
2. Provide guidance and direction in professional
development in infusion related practices.
3. Collaborate and partner with our members and global
organisations across the healthcare sector to promote
a consistent approach to infusion practices.
4. Advance innovative technology and research related to
infusion therapy practices.
5. Maintain the status of IVNNZ Inc. as an incorporated
society.
The Strategic Plan is available on the web site for further
viewing.
Infusion Therapy Standards of Practice
IVNNZ Inc. acknowledges the work of the Infusion Nurses
Society (INS) in the production of the 2016 edition of
Infusion Therapy Standards of Practice and remain
optimistic that the New Zealand(NZ) Directors of
Midwifery and Nursing Services (DOMNS) will endorse this
document to support practice within NZ once formally
approached.
Website
All executive members have a responsibility to maintain
and edit the website: www.ivnnz.co.nz Election to a
recently developed position on the executive team with a
designated responsibility for the website will occur at this
AGM.
Newsletter
IVNNZ Inc. Editor, Catharine O’Hara, has consistently
delivered a quarterly newsletter supported with regular
articles written by educator- Lynette Lennox. Many
members have also contributed articles. Thank you for
your contributions. I would encourage anyone to share
the good work they are doing toward excellence in
infusion management to submit an article. I would like to
acknowledge Catharine for her dedication and many
hours of editorial work.
Finally, I have enjoyed my second term as President of
IVNNZ Inc. and wish to thank all the committee for their
team work, support and advice over the previous four
years.
Kate Laidlow
President IVNNZ Inc.
Jenny Heretini, Clinical Nurse Specialist, Infusion & Related
Therapies employed at Waikato District Health Board and
elected representative of the IVNNZ Inc. Executive
committee, in the role of Educator.
Welcome from your New Educator
It is with great delight and excitement that I take up the
challenge and responsibility of the position of educator for
the next term for IVNNZ Inc. My nursing background
spans almost 30 years with most of those years employed
at Waikato District Health Board working in the Emergency
Department. While employed by Waikato, I acquired my
passion for education and held an educator role for a few
years. I have always adhered to best practice principles
and continue to emulate this and impart my knowledge in
my current role of Clinical Nurse Specialist- Infusion and
Related Therapies.
Over the last two years, I have eased myself into the role
of committee member and have brought to the table my
strengths, particularly contributing towards the weaving of
a cultural component into the IVNNZ Inc. Strategic Plan. In
addition, I have assisted Lynette Lennox (Past Educator)
with the planning and facilitation of the central venous
access device (CVAD) workshops in Auckland and observed
the way in which Lynette’s expertise, experience and
enthusiasm have impacted on each participant. I know I
have “big boots to fill” and will strive to produce high
quality, evidence-based education to our participants.
As IVNNZ Inc. are now endorsing the 2016 Infusion Nurses
Society (INS) Infusion Therapy Standards of Practice, I
thought what better way of becoming familiar with these
than to have a quiz?
If you would like to be included in the draw for a prize,
please email your answers to the 10 questions on the
following page to jennifer.heretini@waikatodhb.health.nz
before June 30, 2018.
Please include your name and mailing address. All correct
entries will be eligible for the draw. The prize will be sent
via mail to your attached address and the winner will be
published in the next IVNNZ Inc.
Education
ISSUE 2 June 2018 Page 6 www.ivnnz.co.nz
The Quiz
1. Does the INS standards encourage validation of
continuing competency yearly, 3 yearly or on an
ongoing basis determined by your organisation
based on risks, incidences and concerns?
2. What are three factors to consider when
choosing the flush volume for Vascular Access
Devices (VAD):
type and size of catheter
size of patient
type of infusion being given
sex of patient
age of patient
3. What is the maximum number of attempts that
should be taken to insert a peripheral vascular
access device?
4. Can you use prefilled 0.9% Sodium Chloride
syringes to reconstitute intravenous medications?
5. Some patients may experience a disturbance in
taste and odour when prefilled 0.9% Sodium
Chloride flushes are used. What is this phenomenon
called?
6. When administering Parenteral Nutrition
without lipids what size micron filter should be
used?
7. You are required to administer antineoplastic
therapy to your patient. You are required to utilise
personal protective equipment (PPE). Choose from
the list below what is required:
double gloves
eye protection if splash a
possibility
gumboots
protective gown
closed system drug transfer
device is able
respiratory protection if
inhalation potential
hat
8. How often should a subcutaneous device access
site be rotated?
at every medication administration
every two days
every 7 days
every 7 days or as clinically indicated
9. An intraosseous access device should be left in
situ for no longer than how many hours?
10. When using adhesive engineered stabilisation
devices it is suggested that barrier solutions should
be used.
Can you use compound tincture
of benzoin as a barrier?
Yes/No? Please explain why or
why not.
All the best with doing some research to answer
these questions and I look forward to receiving your
entries by 30th June 2018.
Kind regards,
Jenny Heretini
Educator IVNNZ
ISSUE 2 June 2018 Page 7 www.ivnnz.co.nz
The 16th Intravenous Nursing New Zealand Inc. (IVNNZ Inc.) 16th – 17th March 2018 Rotorua
Glosan Sadiasa-Manzhula is a registered nurse employed
at Mercy Hospital, Dunedin
Conference theme:
‘An Eruption of the Latest Innovative Practice In Infusion
Therapy’
I had the privilege, along with two other colleagues from
Mercy Hospital, to attend the IVNNZ Inc. two-day
conference held at the Rotorua Holiday Inn. Thank you
for the opportunity.
March 16 was filled with topics about peripherally and
centrally inserted central catheter lines which were
interesting despite my limited exposure to these, being a
Day Surgery Unit nurse. March 17 conference topics
included medication safety, intravenous (IV) flushing, and
responsible cannulation, all of which I hope to impart to
my colleagues as an IV Link Nurse Representative.
Below is a summary of each of the topics:
Are PICCs the CVC of the Future? Dr. Vineet Chopra
Comparing the risk and benefits of peripherally inserted
central catheters (PICCs) with other central venous
catheters (CVCs), the former had shown promising results
having less complications. Findings were based on “real-
world” data from the Michigan Hospital Medicine Safety
Consortium.
There was also evidence presented to support the claim
that the more lumens central or peripheral lines have-the
higher the risk of infection to the patient. Less number of
lumens means less occlusion and less deep vein
thrombus (DVT) rates. The speaker’s final verdict was: It
ALL depends on the patient, the device chosen and the
provider.
Ambiguity- How Guidelines Can Impede Best Practice
Vascular Access Device-related Bloodstream Infection
Prevention Prof. Cathryn Murphy
Infection prevention practices are assured by policies,
guidelines and regulations locally, nationally and globally.
New research and discoveries impact with new standards
for compliance. This speaker discussed challenges in the
uptake of policies due to factors such as staff behavior,
structural workplace variability, ongoing tolerance for
non-compliance and delays in embracing new
technologies. The more prescriptive the rules workers
have imposed on them, the less likely they are to comply.
Decontamination of the Needles Connector: an in vitro
study Julie Flynn
This study compared the decontaminating efficacy of 70%
isopropyl alcohol (IPA) wipe, a 2% chlorhexidine in 70%
IPA wipe and a 70% IPA impregnated cap on needleless
connectors subjected to bacterial and fungal
contamination. Result: the chlorhexidine in 70% IPA wipe
outperformed 70% IPA which had a 30 second
decontamination with a 30% reduction of organisms.
Researchers acknowledged refinement of the research
process needed to include a more defined
decontamination process.
Push-Pull techniques from taking blood from central lines Gill Archer A case study of a patient admitted to Waikato Hospital
with Acute Promyelocytic Leukemia (APML) was
presented. With deteriorating platelet, red blood and
white blood cell counts secondary to chemotherapy and
his pre-diagnosis condition, multiple blood transfusions
were recommended but conflicted with the patient’s
Jehovah Witness beliefs.
Unable to transfuse any blood, staff initiated a push-pull
technique. This technique avoids wasting or discarding any
blood during draws and utilising sodium chloride to pull
out blood from central lines and push it back again until
the blood drawn is suitable for laboratory testing. Trialed
only for this patient, following its success, the technique
was later used for all hematology patients in the ward.
Nursing staff had managed to save a significant amount of
blood for the patient. The standard procedure previously
used for taking bloods meant a minimum 5mLof blood
Conference Report
ISSUE 2 June 2018 Page 8 www.ivnnz.co.nz
was discarded each draw, at least twice daily, from
peripherally inserted central catheters. The patient is
recovering well and was discharged from hospital. It was
good to note that staff had discussed the situation with
the patient and researched to understand the significance
of his major decision to refuse blood transfusions.
Dissociation from the Jehovah Witness group and shunned
by its members may have resulted had the patient
accepted the blood.
IV administration set dwelling time presented by Claire
Rickard
The objective of the study was to compare 4- and 7- day
administration (Infusion) set replacement for the
prevention of infection in central venous and peripheral
arterial catheters. Result: IV administration set
replacement after 7 days was non-inferior to 4 days and
cost-effective. Overall participants = 2941.
Effective PICC securement Elizabeth Culverwell
Canterbury District Health Board (CDHB) introduced a
subcutaneous sutureless securement device following a
four-month trial in 2015, acknowledging that PICC
securement is key to prevent malposition, blood stream
infection, thrombosis, fatal events and re-insertion.
Equally important was the mentoring and coaching in the
use of the introduced method which enhanced staff
engagement, confidence and commitment and eventually
helped in the realization of the programme. High
compliance resulted in desired outcomes such as
improved capability and skill, a display of fiscal
responsibility and markedly reduced PICC migration and
blood stream infection (BSI).
CoolSense® by Rachel Wilson
The Children’s Haematology and Oncology Centre (CHOC)
at Christchurch Hospital trialed an alternative to topical
anaesthetic creams to numb the site of injection for
painful procedures using the CoolSense® pain numbing
applicator.
A qualitative assessment tool (8-Question Survey Monkey)
captured family experiences with the product and its
efficacy over topical anaesthetic creams.
Results: 87% of respondents answered they would
recommend CoolSense® to other patients.
Benefits:
Reduced waiting time
Reduced pain
Reduced cost -CoolSense® device costs $160 and comes
with alcohol cartridge that yields 350+ uses. Emla cream
costs $9 per 5gm single use tube. Potential savings=
$8780 per 1000+ applications.
Medication Safety Continuous Quality Improvement
Catharine O’Hara
Data was collected and analysed from 158 Electronic
Infusion Devices (EID) installed with medication safety
software, which defines dosing limits for the drugs
commonly used within Mid Central District Health Board
(DHB).
Results:
The top 15 drugs and fluids most frequently causing
alerts were identified
Trends demonstrated when the most frequent number
of alerts occurred in a 24 hour time frame
Findings helped make decisions on amendments of the
drug datasets and enabled MidCentral DHB to make
necessary changes to the five clinical profiles ensuring
compliance of medication administration and the
promotion of patient safety.
Pumping in Perth Jenny Heretini
Jenny Heretini, Clinical Nurse Specialist, shared her
experience of attending the 2017 Australian Vascular
Access Society (AVAS) 2nd Scientific Meeting coupled with
the 2016 World Congress on Vascular Access (WoCoVA)
conference highlights.
Medication Safety Then & Now Carolyn Wilson
This is a presentation of the review on the progress made
in reducing adverse drug events in New Zealand since year
2000.
Carolyn previously presented the paper ‘Medication Errors-
the Silent Epidemic’ in 2001, a time when the extent and
severity of harm caused by adverse drug events was still
largely hidden. The years 1999 and 2000 brought to light
the epidemic as talked about on the release of ‘To err is
human. Building a safer health system’ and a full issue of
the British Medical Journal was dedicated to medical error
accordingly. With ongoing progress reviews, themes and
trends in health care settings can now be identified and
future directions discussed.
OPIVA (Out Patient IV Antibiotics) Bev Hopper
This widely accepted, effective, time-tested and safe
therapeutic option in providing treatment for infections
for selected patients in the community setting paved the
way for Aged Residential Care (ARC) facilities to be
involved with the management of patients requiring IV
ISSUE 2 June 2018 Page 9 www.ivnnz.co.nz
antibiotic administration instead of keeping them as
inpatients in a hospital setting. E-learning packages,
practical workshops for central line management and IV
antibiotic administration, policies, and ongoing support
are provided to ARC nurses and participating community
workers.
IV Flushing & Patency: Not As Simple As You Think
Presenter: Samantha Keogh
Don’t rush your flush- NO MORE THAN 1ML/SEC
Regular flushing and locking aims to prevent occlusion
and infection by minimising the build-up of biofilm or
other substances inside the catheter lumen. Several IV
flush studies had previously highlighted inconsistences
with flushing and infusion practices and also adherence
to aseptic non-touch technique (ANTT) principles. This
presentation showed the impact of IV flushing and
infusions on vascular access devices (VAD) which were
digitally recorded for good visualisation. Varied flushing
speeds were tested and recorded using laminar versus
pulsatile flow. Turbulent flows (140cm/sec) caused minor
tip flexion of the IV catheter tip in the vessel lumen.
Ejection velocity of >200cm/sec demonstrated IV
catheter tip flexion. It is worth noting, that the aim of a
good IV maintenance practice is to minimize secondary
(post IV insertion) injury and inflammation. Catheter tip
friction to vessel surface has implications on vessel health
and outcome of VAD maintenance. Additionally, good
judgment on catheter size selection matters.
INS Recommendations:
Assessment of catheter and site
Aspiration of blood
Pre/post drug administration
At least Q24H flushing if not in use
Use of manufacturer prepared pre-filled syringe
Volume at least x2 the length and diameter of the
catheter
Use of gentle, pulsatile technique(except post-blood
transfusion and some drugs)
Expected outcomes of quality IV insertion & care:
Insertion of the right device, by the right person, the
first time
The device is maintained without complications for the
duration of the treatment until it is removed
PRICT (Practice Responsible Intravenous Cannulation
Today) Project Lynne Gledstone-Brown
‘Just in case’ cannulas create opportunities for unjustified
patient risk or harm. Although often an essential
procedure, the benefits must be weighed against the
risks, and necessity against convenience.
Research shows 50% of patients presenting to emergency
departments who receive IV cannulations don’t actually
need them. Wellington Emergency Department sought to
embark on a patient centered quality initiative to
encourage critical thinking and assessment to improve
the cannulation care they provide.
PRICT implementation involved:
Re-arranging of cannulas and venipuncture consumables
Identifying champions
Stickers
Introduction of guidelines for peripheral intravenous
cannula (PIVC) insertion
Regular follow-up audits
Results:
30% reduction in PIVC insertion
17% increase in venipuncture
Huge cultural shift within the department as a whole
$5889.50 savings per month
Reduced risk of infection
Risk of bloodstreams and venous infections in 12623
peripheral IV catheters in Australia Claire Rickard
The objective of the study was to quantify risk of primary
bloodstream and local infections with PIVCs and to assess
relationship to dwell time.
Result: There was no increase in BSI risk with dwell time.
Infections did occur from Day 2 to Day 7 in 1-19 days
dwell time but at a very low rate and no trend was
detected over time. Complex patients were most at risk.
Each day of dwell is a risk, but later days are not anymore
risky than earlier days.
MAGIC (Michigan Appropriateness Guide for
Intravenous Catheters Dr. Vineet Chopra
MAGIC is an evidenced-based tool which originated in
Michigan to provide criteria for the appropriate use of a
PICC.
ISSUE 2 June 2018 Page 10 www.ivnnz.co.nz
All the presenters did an awesome job. I couldn’t be any
more grateful to be part of Intravenous Nursing New
Zealand. As part of the IV Link Nurse team in Mercy
Hospital, I take pride in my role.
The venue, food, and hosts were outstanding and I’m sure
IVNNZ Inc. will consider suggestions from participants. In
particular, to ensure that abstracts are showcased and
evaluated according to category. For example: funded
research versus local initiatives.
Delegates from Mercy Hospital (Glosan, second from the
right)
It was also a cultural enrichment for me as I was able to
visit the “Living Maori Village” just behind the venue and
learned so much.
Update on Change to PHARMAC Bulk Fluids In March 2018, PHARMAC announced the decision about national procurement activity for intravenous (IV) fluid bags and a range of irrigation solutions, collectively referred to as bulk fluids.
We know these changes will be of interest to District Health Board (DHB) IV nurses, and wanted to update you on the following activities that will be undertaken to support DHBs with these changes.
We have identified and communicated with key staff within each DHB, from procurement, pharmacy or both, who will be primarily managing the change in the first instance.
A number of resources are being developed that will include;
A summary of the product changes
Product information including photos of the new products
Schedule listing and Hospital Supply Status (HSS) dates for each new product
Supplier and product codes
Supplier contact details.
Key messages for staff about the change including recycling messages
The resources will be sent to these key staff no later than Monday 21 May 2018 to use and/or to distribute to other relevant DHB staff. The Pharmaceutical Schedule listing dates for the first of the products with new suppliers start from 1 June 2018.
Two suppliers – B. Braun and Fresenius Kabi supply the majority of IV fluids and irrigation solutions that will change from the current supplier. They intend to provide training to DHB staff about how to use their products. If you are not aware of training occurring in your DHB and would like training please contact:
Fresenius Kabi: Susan O’Connell Susan.OConnell@fresenius-kabi.com B. Braun (NZ) 0800 227 286.
If you have any questions relating to
PHARMAC bulk fluids
implementation activities please
contact the PHARMAC
implementation leads for this
activity, Angela Cathro
angela.cathro@pharmac.govt.nz or
Bronwyn Locke
I
ISSUE 2 June 2018 Page 11 www.ivnnz.co.nz
An Eruption of the Latest Innovative
Practices in Infusion Therapy: 2018 Conference Feedback Report
Collated by Ellen Jones, IVNNZ Inc. Secretary
A total of 68 delegates completed the Conference Feedback and Evaluation Questionnaire forms.
Question 1. How did you hear about this conference? Delegates had the opportunity to tick more than one box for this question.
This year, the website and word of mouth were the two most popular methods for conference advertising. Delegates who ticked other were informed of the conference by either their manager or through a workplace meeting. The flyer and the email methods remain popular and accounted for 25% each. A conclusion can be drawn that the conference was well advertised and these four methods should continue to be used.
Question 2. Please specify your reason for attending this conference Most delegates ticked more than one box. The most popular reason for attending the conference was for their own professional development.
Question 3: Please indicate your overall satisfaction with content and delivery This question allowed the delegates to score their level of satisfaction from very satisfied to very dissatisfied. The keynote speakers especially Dr., Vineet Chopra was an obvious success.
Question 4. I can put what I learned to immediate use?
Question 5. Please indicate your overall satisfaction with this conference Even though many verbal and written comments were made about the catering standard the overall scoring was between neutral to somewhat satisfied.
Question 6. What were the strengths of the conference? I have collated the top 10 answers 1.Keynote speakers 2.Invited speakers especially Karen Winterbourne 3.Networking 4.Wide/varied range of topics covered 5.Knowledge and passion of speakers 6.Well organised conference 7.Patient experience 8.Trade displays 9.New data 10.Informative and up-to-date
Question 7. What were the weaknesses of the conference? 1.Cold venue 2.Uncomfortable chairs 3.Poor acoustics 4.Light behind speakers too bright 5.Posters too isolated
Question 8. Would you recommend this conference to others? Question 9. What speakers or topics would interest you for the IVNNZ Inc. Conference in 2018? I have collated the top 5 answers 1.The use of ultrasound guided insertion 2.Consider a different stream for scientific presenters in regards to the awards 3.Would be good to have two streams for best presenter. Having a scientific stream and a clinical stream 4.Ports/power ports 5. Have practical workstations
Conference Feedback
ISSUE 2 June 2018 Page 12 www.ivnnz.co.nz
ISSUE 2 June 2018 Page 13 www.ivnnz.co.nz
ISSUE 2 June 2018 Page 14 www.ivnnz.co.nz
ISSUE 2 June 2018 Page 15 www.ivnnz.co.nz
ISSUE 2 June 2018 Page 16 www.ivnnz.co.nz
IVNNZ Inc. Executive Committee minutes: available on the website for members
IVNNZ Inc. Education, Study and Research Grants
details for members are available on the website.
Meetings
IVNNZ INC. EXECUTIVE COMMITTEE MEETINGS
When 4 May 2018
Where Wellington
When 20-21 July 2018
Where Te Awamutu
When 2 November 2018
Where Wellington
National
Educational Events
CVAD WORKSHOP
When 10 August 2018
Where Auckland
When 9 November 2018
Where Auckland
IVNNZ Inc. Welcomes New Members
Membership application form - IVNNZ
Inc. invites you to join
If you have a passion for Infusion Therapy and
your practice is important to you, we need
you to be part of this organisation.
Your membership application can be
completed online or download an application
form and send by e-mail.
The Membership application process and
rules are available via the website:
http://www.ivnnz.co.nz/membership-login/New-Members
http://www.ivnnz.co.nz/about-ivnnz-inc./Rules-of-IVNNZ-Inc
International
WOCOVA 5TH CONFERENCE
When 20-22 June 2018
Where Copenhagen Denamrk
AVA 2018 ANNUAL SCIENTIFIC MEETING https://www.eventscribe.com/2018/AVA
When 15-18 September 2018
Where Colubus Convention Center, Clumbus, Ohio USA
INS ANNUAL CONVENTIONS AND INDUSTRIAL EXHIBITIONS https://www.ins1.org/default.aspx
When May 2019
Where USA (Venue TBC)
IVNNZ Inc. encourages
members to apply for
educational assistance in the
form of Scholarship or Grants.
You are eligible to apply for a
Grant every three years to
attend conference.
The successful applicant receives up to $3000 and
$5000 to attend Australasian and European/
American conferences respectively.
ISSUE 2 June 2017 Page 17 www.ivnnz.co.nz
Covering all aspects of Anatomy, Insertion,
Care, Maintenance, Complications, and
Clinical Workstations
Friday 25th May
Friday 10th August
Friday 9th November
0830-1530hrs
Holiday Inn
2 Ascot Road Airport Oaks
Auckland
$50 IVNNZ members
$100 Non members
Morning tea/lunch provided
Please register online
http://www.ivnnz.co.nz/page/Workshops
20
18 I
VN
NZ
Inc.
CV
AD
Wo
rksh
op
Payment required at booking to secure place on workshop
COPY DEADLINE
We welcome your input into the newsletter. Please forward articles, correspondence or ideas to the
Editor prior to 20th August 2018.
Any comments made in the newsletter are not necessarily the view of the IVNNZ Inc. Executive.
Product Information is supplied by the manufacturers and is published in this newsletter to inform
readers. No endorsement is implied or intended by IVNNZ Inc.
ISSUE 2 June 2017 Page 18 www.ivnnz.co.nz
IVNNZ Inc. Executive Committee
PRESIDENT Lynette Lennox P (07) 839 8899 ext 23595 M (021) 846 385 E president@ivnnz.co.nz
IMMEDIATE PAST PRESIDENT Kate Laidlow P (07) 348 1199 ext 8058 M (027) 839 6564 E kate.laidlow@lakesdhb.govt.nz
SECRETARY Ellen Jones P (027) 225 5032 E secretary@ivnnz.co.nz
TREASURER Fiona Williams P (07) 579 8517 E treasurer@ivnnz.co.nz
EDUCATOR Jenny Heretini M (021) 759 539 E educator@ivnnz.co.nz
WEBSITE Cheryl Phillips P (021) 152 1411 E website@ivnnz.co.nz
EDITOR Ally Hale P (03) 687 1230 ext 260 E editor@ivnnz.co.nz
PRIVATE SECTOR Ally Hale P (03) 687 1230 ext 260 E ally@bidwillhospital.co.nz
Corporate Members of IVNNZ Inc.
top related